Help for Your Patients

• Should Your Patient Be Tested
• Your Newly Diagnosed Patient
• Managing Your AAT Deficient Patient

The resources in this section are designed to help your Alpha-1 patients effectively manage their condition.

Of particular interest is the ARALAST AATmosphere Program, which offers a comprehensive support program for Alphas and their families.

Insurance coverage is often a concern for Alphas and their families. Visit the Insurance Assistance page for a listing of helpful services.

Your patients can learn more about AAT Deficiency with the Patient Education Kits and Brochures.

We encourage you to refer your patients to the Patients and Families side of Alpha1Health.com for a wealth of useful information and helpful resources.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information